News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
141 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (29317)
Month
January (3217)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (190)
2 (123)
5 (141)
6 (141)
7 (169)
8 (187)
9 (100)
12 (133)
13 (138)
14 (122)
15 (129)
16 (48)
19 (83)
20 (66)
21 (95)
22 (49)
23 (90)
24 (1)
26 (99)
27 (109)
28 (135)
29 (105)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
24
26
27
28
29
30
Press Releases
NervGen Pharma to Present at the Canaccord Genuity 44th Annual Growth Conference
August 6, 2024
·
4 min read
Gene therapy
BioMarin Narrows Roctavian Efforts to U.S., Germany, Italy as Sales Stagnate
BioMarin Pharmaceuticals on Monday said it is restricting sales of its hemophilia A gene therapy to three countries in an effort to reduce costs and help the treatment become profitable by 2025.
August 6, 2024
·
2 min read
·
Tristan Manalac
Cancer
Actinium to Farm Out AML Radioactive Drug After FDA Asks for Another Trial
The FDA is looking for stronger overall survival data to back Actinium’s application for Iomab-B, an investigational therapy that will allow acute myeloid leukemia patients to receive bone marrow transplants.
August 6, 2024
·
2 min read
·
Tristan Manalac
Mergers & Acquisitions
Mallinckrodt Offloads Therakos Photopheresis Business to CVC Capital Partners for $925M
The specialty pharmaceutical company has twice filed for bankruptcy in recent years, driven by opioid-related litigation. Mallinckrodt’s deal with CVC will allow it to pay off more than half of its net debt.
August 6, 2024
·
2 min read
·
Tristan Manalac
Drug Development
SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug
August 6, 2024
·
4 min read
Drug Development
SELLAS Receives EMA Orphan Drug Designation for SLS009 for Treatment of Peripheral T-cell Lymphomas
August 6, 2024
·
4 min read
Business
SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024
August 6, 2024
·
1 min read
Business
Sofwave Medical Reports Second Quarter and First Half 2024 Financial Results and Business Highlights
August 6, 2024
·
3 min read
Business
Inozyme Pharma Reports Second Quarter 2024 Financial Results and Provides Business Highlights
August 6, 2024
·
13 min read
Drug Development
Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing
August 6, 2024
·
5 min read
Previous
9 of 15
Next
